2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy Grant US-11504368-B2 United States of America 22 Nov 2022
A COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES Application WO-2022035308-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022